Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aging and vasodilation to atrial peptides.

J T Emmick, M L Cohen

    Clinical and Experimental Hypertension. Part A, Theory and Practice
    |January 1, 1986
    PubMed
    Summary

    Vascular relaxation to atrial peptides shows minimal age-related decline in rats. Arterial and in vivo responses suggest potential for therapeutic atrial peptide agents in aging cardiovascular disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The design and conduct of clinical trials to limit missing data.

    Statistics in medicine·2012
    Same author

    A prototype cloud physics laser nephelometer.

    Applied optics·2010
    Same author

    Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome.

    Neurology·2009
    Same author

    Foliar washoff of pesticides by rainfall.

    Environmental science & technology·2009
    Same author

    Neuronal binucleation in Alzheimer disease hippocampus.

    Neuropathology and applied neurobiology·2007
    Same author

    Rasmussen syndrome and CNS granulomatous disease with NOD2/CARD15 mutations.

    Neurology·2007

    Area of Science:

    • Cardiovascular Physiology
    • Aging Research
    • Pharmacology

    Background:

    • Atrial peptides influence cardiovascular function, with potential links to age-related pathologies like hypertension.
    • Understanding age-related changes in atrial peptide responsiveness is crucial for developing effective treatments.

    Purpose of the Study:

    • To investigate the impact of animal age on vascular relaxation responses to atrial peptides.
    • To determine if age affects the efficacy of atrial peptides in altering blood pressure.

    Main Methods:

    • In vitro assessment of atrial peptide-25 (AP-25) and atrial peptide-21 (AP-21) induced relaxation in rat aorta, carotid artery, mesenteric artery, and portal vein across different ages.
    • In vivo evaluation of AP-25's effect on blood pressure in rats of varying ages.

    Main Results:

    • Arteries from younger rats (1-2 months) exhibited the greatest in vitro relaxation to AP-25, but older rats (up to 18-19 months) retained significant responsiveness (~80% of maximal).
    • Portal veins showed similar relaxation responses to AP-25 across all ages.
    • Intravenous AP-25 lowered blood pressure similarly in rats of all ages, irrespective of in vitro arterial sensitivity differences.

    Conclusions:

    • Vascular responsiveness to atrial peptides does not significantly decline with advanced age in rats.
    • The blood pressure-lowering effect of atrial peptides may involve mechanisms beyond direct arterial relaxation, such as alterations in venous return or cardiac output.
    • These findings support the development of therapeutic strategies targeting atrial peptide pathways for age-related cardiovascular conditions.

    Related Experiment Videos